Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-menC conjugate vaccine era, 2009-2013

Journal of Medical Microbiology

Volumn 64, Issue 2, 2015, Pages 174-179

  Tsang, Raymond S W ^a   Hoang, Linda ^b   Tyrrell, Gregory ^c   Horsman, Greg ^d   Wylie, John ^c   Jamieson, Frances B ^e,f   Lefebvre, Brigitte ^g   Taha, Muhamed Kheir ^h  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b BCCDC Public Health Microbiology and Reference Laboratory   (Canada)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^d Saskatchewan Disease Control Laboratory   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^h INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; FACTOR H-BINDING PROTEIN, NEISSERIA MENINGITIDIS; FRPB PROTEIN, BACTERIA; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; PORIN; PORIN PROTEIN, NEISSERIA; SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE;

ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CANADA; CANADIAN; FHBP GENE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE SEQUENCE; GENOTYPE; NADA GENE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MENINGITIS, MENINGOCOCCAL; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEISSERIA MENINGITIDIS, SEROGROUP C; PORINS; SEQUENCE ANALYSIS, DNA; SEROGROUP; YOUNG ADULT;

EID: 84921893003     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000006-0     Document Type: Article

References (29)

1. Abdillahi, H. & Poolman, J. T. (1987). Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48, 367-371.
2. Ashton, F. E., Ryan, J. A., Borczyk, A., Caugant, D. A., Mancino, L. & Huang, D. (1991). Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 29, 2489-2493.
3. Caugant, D. A., Bøvre, K., Gaustad, P., Bryn, K., Holten, E., Høiby, E. A. & Frøholm, L. O. (1986). Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 132, 641-652.
4. Claus, H., Elias, J., Meinhardt, C., Frosch, M. & Vogel, U. (2007). Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. J Clin Microbiol 45, 2960-2964.
5. De Wals, P., Deceuninck, G., Lefebvre, B., Boulianne, N. & De Serres, G. (2011). Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada. Pediatr Infect Dis J 30, 566-569.
6. Elias, J. & Vogel, U. (2007). IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J Clin Microbiol 45, 159-167.
7. Frasch, C. E., Zollinger, W. D. & Poolman, J. T. (1985). Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7, 504-510.
8. Harrison, O. B., Brueggemann, A. B., Caugant, D. A., van der Ende, A., Frosch, M., Gray, S., Heuberger, S., Krizova, P., Olcen, P. & other authors (2011). Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology 157, 2181-2195.
9. Hill, A. B. (1977). A Short Textbook of Medical Statistics. London: Hodder & Stoughton.
10. Hong, E., Giorgini, D., Deghmane, A. E. & Taha, M. K. (2012). Functional impacts of the diversity of the meningococcal factor H binding protein. Vaccine 31, 183-189.
11. Jamieson, F. B., Rawte, P., Deeks, S. L., Zhou, J., Law, D. K. S., Deng, S. & Tsang, R. S. W. (2013). Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001-2010. J Med Microbiol 62, 46-55.
12. Jelfs, J., Munro, R., Ashton, F. E. & Caugant, D. A. (2000). Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect 125, 285-298.
13. Kinlin, L. M., Jamieson, F., Brown, E. M., Brown, S., Rawte, P., Dolman, S., Drews, S. J. & Fisman, D. N. (2009). Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine 27, 1735-1740.
14. Law, D. K. S., Stoltz, J., Henderson, A. M. & Tsang, R. S. W. (2005). Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003. Can J Microbiol 51, 523-530.
15. Law, D. K. S., Zhou, J., Deng, S., Hoang, L., Tyrrell, G., Horsman, G., Wylie, J. & Tsang, R. S. W. (2014). Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from western Canada, 2009 to 2013. J Med Microbiol 63, 1490-1499.
16. Li, Y. A., Tsang, R., Desai, S. & Deehan, H. (2014). Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011. Can Commun Dis Rep 40, 160-169.
17. Lucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., Vallely, P. J., Oster, P., Pizza, M. & other authors (2010). Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol 17, 919-929.
18. Lucidarme, J., Tan, L., Exley, R. M., Findlow, J., Borrow, R. & Tang, C. M. (2011). Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 18, 1002-1014.
19. Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K. & other authors (1998). Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95, 3140-3145.
20. Marsh, J. W., O’Leary, M. M., Shutt, K. A. & Harrison, L. H. (2007). Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. J Clin Microbiol 45, 1333-1335.
21. NACI (2013). An Advisory Committee Statement (ACS) update on the use of quadrivalent conjugate meningococcal vaccines. Can Commun Dis Rep 39, 1-40.
22. Pollard, A. J., Tam, T. W. S. & National Immunization Committee on Immunization (2011). An Advisory Committee Statement on the recommended use of meningococcal vaccines. Can Commun Dis Rep 27, 2-36.
23. Richmond, P. C., Marshall, H. S., Nissen, M. D., Jiang, Q., Jansen, K. U., Garcé s-Sánchez, M., Martinón-Torres, F., Beeslaar, J., Szenborn, L. & other authors (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, singleblind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12, 597-607.
24. Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T. & Hughes, J. M. (2001). Meningococcal disease. N Engl J Med 344, 1378-1388.
25. Santolaya, M. E., O’Ryan, M. L., Valenzuela, M. T., Prado, V., Vergara, R., Muñoz, A., Toneatto, D., Grañ a, G., Wang, H. & other authors (2012). Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 379, 617-624.
26. Sloan, A. M., Henderson, A. M. & Tsang, R. S. W. (2008). Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: epidemiological links to returning travellers. Can J Infect Dis Med Microbiol 19, 227-232.
27. Vogel, U., Claus, H., Frosch, M. & Caugant, D. A. (2000). Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol 38, 941-942.
28. Zhou, J., Jamieson, F., Dolman, S., Hoang, L. M., Rawte, P. & Tsang, R. S. W. (2012a). Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: a decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009. Can J Infect Dis Med Microbiol 23, e55-e59.
29. Zhou, J., Lefebvre, B., Deng, S., Gilca, R., Deceuninck, G., Law, D. K. S., De Wals, P. & Tsang, R. S. W. (2012b). Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003. J Clin Microbiol 50, 1545-1551.